Related Experiment Video
Updated: Jan 28, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis
Sirish K Palle1,2, Kushal B Naik1,3, Courtney E McCracken2
1Transplant Services, Children's Healthcare of Atlanta (CHOA), Atlanta, Georgia.
Insights
Pediatric autoimmune hepatitis (AIH) in African American (AA) children presents with more severe disease, higher transplant risk, and increased recurrence post-transplant compared to non-AA children. Further research into underlying factors is crucial.
Area of Science:
- Pediatric Hepatology
- Autoimmune Diseases
- Transplantation Immunology
Background:
- Autoimmune hepatitis (AIH) studies in children predominantly feature Caucasian cohorts.
- Pediatric AIH in African Americans (AA) is understudied, lacking predictors for outcomes and often leading to severe complications or mortality.
Purpose of the Study:
- To define disease presentation, progression, therapy response, and outcomes in pediatric AIH within a diverse, single-center cohort.
- To identify clinical predictors of outcome in African American children with AIH.
Main Methods:
- Retrospective review of pediatric AIH patients at a tertiary liver transplant center.
- Assessment of clinical and laboratory data to compare disease presentation, progression, and outcomes between AA and non-AA children.
Main Results:
- African Americans comprised 42% of the cohort; they received higher steroid doses and presented more frequently with end-stage liver disease (ESLD).
- AA children faced a 4.5-fold higher risk of liver transplant or death within 12 months.
- Post-transplant AIH recurrence was significantly higher in AA (50%) versus non-AA (8%) patients.
Conclusions:
- African American pediatric AIH patients exhibit a higher likelihood of presenting with ESLD and face increased early transplant risk.
- Disease recurrence post-transplantation is a significant concern in AA children with AIH.
- Further studies are needed to explore biological, genetic, and access-to-care factors; early referral and tailored immunosuppression are recommended for AA patients.
Background & Aims:
Most studies on autoimmune hepatitis (AIH) in children are in predominantly Caucasian cohorts. Paediatric AIH in African Americans (AA) is understudied, with a dearth of clinical predictors of outcome, often leading to serious complications and even mortality. The aim of the study was to define disease presentation, progression, response to therapy and outcomes in paediatric AIH in a well-defined, large, single centre, demographically diverse population.
Methods:
We conducted a review of patients with AIH who were followed at this tertiary liver transplant centre. Clinical and laboratory covariates were assessed with regard to disease presentation, progression and outcomes in AA vs Non-AA children.
Results:
African Americans patients constituted 42% of this cohort. At 1-year follow-up, AA children were receiving significantly higher doses of steroids compared to non-AA. More AA presented with end-stage liver disease (ESLD) with high immunoglobulin G and GGT:platelet ratio. After adjusting for other risk factor variables like gender, age at presentation and ESLD, AA children were at 4.5 times higher risk for significant outcome liver transplant/death within the first 12 months of presentation. Post-transplant, recurrent AIH was seen in 50% of AA vs 8% in non-AA.
Conclusions:
African American patients with AIH are more likely to present with ESLD and have an increased early risk for transplantation with high likelihood of disease recurrence post-transplantation. Studies are needed to delineate factors such as inherent biology, genetics and access to care. Early referral and tailored immunosuppressive regimens are required for AA patients with AIH.
Related Concept Videos
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Strategies of Self-Presentation I: Strategic Self-Presentation
Processes of Self-Presentation
Predicting Reaction Outcomes
Strategies of Self-Presentation II: Self-Verification

